Home > Financial Ratios > MANKIND PHARMA

MANKIND PHARMA
EV/EBIT

    Back to All Ratios
MANKIND PHARMA is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
Best Quarterly Growth Large Cap Stocks
AD     Remove this Ad

MANKIND PHARMA Last 5 Year EV/EBIT History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EV/EBIT(x) 36.5437.63-0.150.25-0.25

What is the latest EV/EBIT ratio of MANKIND PHARMA ?

The latest EV/EBIT ratio of MANKIND PHARMA is 36.54 based on Mar2025 Consolidated results.
Year EV/EBIT
Mar202536.54
Mar202437.63
Mar2023-0.15
Mar20220.25
Mar2021-0.25

How is EV/EBIT of MANKIND PHARMA Trending?

Years EV/EBIT % Change
Mar2025 36.54
-2.90
Mar2024 37.63
Positive
Mar2023 -0.15
Negative
Mar2022 0.25
Positive
Mar2021 -0.25 -

Other Financial Ratios of MANKIND PHARMA


Compare EV/EBIT ratio of peers of MANKIND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MANKIND PHARMA ₹87,715.9 Cr 1.1% -1.3% -16.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹382,694.0 Cr -2.3% -7.3% -12.8% Stock Analytics
DIVIS LABORATORIES ₹160,721.0 Cr 0.8% -5.8% 4.7% Stock Analytics
TORRENT PHARMACEUTICALS ₹134,016.0 Cr 0.8% 3.7% 20.8% Stock Analytics
CIPLA ₹106,946.0 Cr 0.7% -11.2% -6.5% Stock Analytics
DR REDDYS LABORATORIES ₹101,691.0 Cr -1.4% -3.8% -1.3% Stock Analytics


MANKIND PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
MANKIND PHARMA

1.1%

-1.3%

-16.1%

SENSEX

-0.1%

-2.9%

7.5%


You may also like the below Video Courses